Primary Peritoneal Carcinoma Withdrawn Phase 1 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01138137N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian CancerTreatment